ZTS

Zoetis closed at $81.03, a 1.18% drop from the previous day. The decline was larger than the overall market movement.

Is IDXX a good stock to buy? We came across a bullish thesis on IDEXX Laboratories, Inc. on Astute Optics – US’s Substack. In this article, we will summarize the bulls’ thesis on IDXX. IDEXX Laboratories, Inc.’s share was trading at $553.48 as of October 21st 2026. IDXX’s trailing and forward P/E were 36.65 and 31.45 respectively […]

The article questions how unusual Zoetis's recent sales growth is.

Zoetis offers diversification and stability, while ImmuCell has stronger sales growth and expansion potential. The piece compares the two as investment options.

Zoetis received FDA approval for Convenia® RTU for Dogs, a single-injection antibiotic that can treat skin infections for up to 14 days.

Zoetis is rated sell as growth slows and guidance falls, with weakening fundamentals outweighing the discount.

Investing.com -- Jefferies downgraded Zoetis and Elanco to Hold from Buy on Tuesday, warning that pricing power in animal health is at risk. The firm reiterated its Buy rating on IDEXX Laboratories.

Pre-Market Stock Futures: Futures are mixed, but Nasdaq futures are lower as chipmakers come under attack this morning. The AI trade made a Monday comeback after a dreadful period last week. The Goldman Sachs (NYSE: GS) upgrade of CoreWeave (NASDAQ: CRWV) was a lynchpin in Monday’s move higher, despite the shares actually closing flat on the […]